Stay updated on Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial

Sign up to get notified when there's something new on the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The site revision label was updated from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-18T01:38:16.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The clinical trial page now displays the study record for Yttrium-90, ipilimumab, and nivolumab in uveal melanoma with liver metastases, including study details, eligibility criteria, treatment arms, outcomes, and locations.
    Difference
    50%
    Check dated 2026-11-10T22:44:42.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The displayed site revision changes from v3.7.2 to v3.8.0 while the page remains a 403 Forbidden screen.
    Difference
    0.2%
    Check dated 2026-11-03T22:53:40.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    An NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence,” while the site revision advances from v3.7.1 to v3.7.2. The study record itself remains a 403 error page.
    Difference
    1%
    Check dated 2026-10-20T22:08:22.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.1 instead of v3.7.0; the page remains a 403 error page.
    Difference
    0.2%
    Check dated 2026-10-06T21:53:13.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record content with an access-restricted message.
    Difference
    18%
    Check dated 2026-09-22T22:17:48.000Z thumbnail image

Stay in the know with updates to Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page.